Guangzhou, China

Qian Wang

This inventor holds 6 USPTO granted patents. Top assignees: South China Normal University, Cooper Technologies Company, Guangzhou N Biomed Ltd.. Active years: 2011-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qian Wang. Retrieved from https://idiyas.com/inventor/qian-wang-9sugf8ji

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2011-2024

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Qian Wang

Introduction

Qian Wang is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of immunology and drug development, holding a total of six patents. His work focuses on innovative solutions for combating viral infections and developing therapeutic agents.

Latest Patents

One of Qian Wang's latest patents is the "AD35-vectored immunogenic composition for SARS-COV-2 infection." This invention discloses a replication-defective Ad35-vectored immunogenic composition designed to induce an immune response against SARS-CoV-2. The composition includes an Ad35 vector that encodes an optimized nucleic acid sequence. The findings suggest that this immunogenic composition can produce more S proteins in human cells, enhancing safety and convenience. It may also be used in combination with other immunogenic compositions or as a therapeutic agent for COVID-19.

Another significant patent is related to "Myrtle polysaccharide P1, the separation method thereof and the use in preparing hypolipidemic drugs." This invention details a myrtle polysaccharide P1, which contains various sugars and demonstrates the ability to bind cholate in vitro. The experimental results indicate that the myrtle polysaccharide P1 has a binding rate to sodium taurocholate, sodium glycocholate, and sodium cholate, showcasing its potential in hypolipidemic drug development.

Career Highlights

Qian Wang has worked with prominent institutions, including South China Normal University and Cooper Technologies Company. His experience in these organizations has contributed to his innovative research and development efforts.

Collaborations

Qian Wang has collaborated with notable colleagues, including Ruqiang Huang and Jinghui Wang, who have supported his research endeavors.

Conclusion

Qian Wang's contributions to the fields of immunology and drug development are noteworthy. His innovative patents reflect his commitment to advancing medical science and improving therapeutic options for viral infections and related health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…